Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01383018 · ClinicalTrials.gov registry record
PROPPER Prospective Registry of Outcomes With Penile Prosthesis
A clinical trial, sponsored by Boston Scientific Corporation.
- Completed
- Registry status
- 1,457
- Enrollment target
NCT01383018: Completed study, sponsored by Boston Scientific Corporation.
NCT01383018 is a clinical trial that has completed, run by Boston Scientific Corporation. The registered enrollment target is 1,457 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01383018 has completed, sponsored by Boston Scientific Corporation.
- COMPLETED
- Registry status
- 1,457 participants
- Enrollment target
Study Summary
The purpose of this observational registry is to collect and better understand "real-world" outcomes for men undergoing penile implant surgery to treat erectile dysfunction.
Primary Outcome
Penile prosthesis overall subject satisfaction (effectiveness objective 1) measured using a non-validated, standard question, evaluated overall and by penile prosthesis.
Interventions
- DEVICE AMS Penile Prosthesis Devices
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,457 participants |
| Start Date | 2011-06-13 |
| Est. Completion | 2018-07-25 |
What the finished NCT01383018 record still lists
NCT01383018 is an observational study that tracks outcomes without assigning an intervention. Its 1,457 participants enrollment target places it among the larger protocols in the corpus.
The record links to 0 conditions, and to 1 intervention - of which AMS Penile Prosthesis Devices is the first listed.
NCT01383018 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01383018 about?
NCT01383018 is a clinical study titled "PROPPER Prospective Registry of Outcomes With Penile Prosthesis". The purpose of this observational registry is to collect and better understand "real-world" outcomes for men undergoing penile implant surgery to treat erectile dysfunction.
What is the current status of trial NCT01383018?
This trial is currently completed. The enrollment target is 1,457 participants. The study started on 2011-06-13. Estimated completion is 2018-07-25.
What interventions are being tested in trial NCT01383018?
The interventions under investigation include: AMS Penile Prosthesis Devices (DEVICE).
Who is sponsoring clinical trial NCT01383018?
This trial is sponsored by Boston Scientific Corporation, which has 280 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03936361 · 1,456 participants · Phase 3
Statins In Intracerbral Hemorrhage
- NCT06782347 · 1,454 participants · NA
Activating SilverSneakers Benefits for Seniors With Osteoarthritis
- NCT04566328 · 1,450 participants · Phase 3
Testing the Use of Combination Therapy in Adult Patients With Newly Diagnosed Multiple Myeloma, the EQUATE Trial
- NCT05229341 · 1,450 participants · NA
Evaluation of DNA Methylation Signatures for the Diagnosis and Management of Thyroid Nodules
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI